A detailed history of Trinity Point Wealth, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 258 shares of REGN stock, worth $181,077. This represents 0.04% of its overall portfolio holdings.

Number of Shares
258
Previous 266 3.01%
Holding current value
$181,077
Previous $279,000 2.87%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1024.09 - $1201.76 $8,192 - $9,614
-8 Reduced 3.01%
258 $271,000
Q2 2024

Jul 30, 2024

BUY
$883.2 - $1071.19 $6,182 - $7,498
7 Added 2.7%
266 $279,000
Q1 2024

May 08, 2024

SELL
$902.69 - $993.35 $2,708 - $2,980
-3 Reduced 1.15%
259 $249,000
Q4 2023

Feb 08, 2024

BUY
$775.18 - $881.7 $9,302 - $10,580
12 Added 4.8%
262 $230,000
Q3 2023

Nov 08, 2023

BUY
$692.45 - $844.37 $173,112 - $211,092
250 New
250 $205,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Trinity Point Wealth, LLC Portfolio

Follow Trinity Point Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.